Salminen Alec, Hill Kayli, Henry Chung L, James McGrath L, Johnson Dean G
Annu Int Conf IEEE Eng Med Biol Soc. 2018 Jul;2018:5814-5817. doi: 10.1109/EMBC.2018.8513538.
Improving the health outcomes for end-stage renal Disease (ESRD) patients on hemodialysis (HD) requires new technologies for wearable HD such as a highly efficient membrane that can achieve standard toxic clearance rates in small device footprints. Our group has developed nanoporous silicon nitride (NPN) membranes which are 100 to 1000 times thinner than conventional membranes and are orders-ofmagnitude more efficient for dialysis. Counter flow dialysis separation experiments were performed to measure urea clearance while microdialysis experiments were performed in a stirred beaker to measure the separation of cytochrome-c and albumin. Hemodialysis experiments testing for platelet activation as well as protein adhesion were performed. Devices for the counter flow experiments were constructed with polydimethylsiloxane (PDMS) and a NPN membrane chip. The counter flow devices reduced the urea by as much as 20%. The microdialysis experiments showed a diffusion of ~ 60% for the cytochrome-c while clearing ~ 20% of the Albumin. Initial hemocompatibility studies show that the NPN membrane surface is less prone to both protein adhesion and platelet activation when compared to positive control (glass).
改善接受血液透析(HD)的终末期肾病(ESRD)患者的健康状况需要用于可穿戴式血液透析的新技术,例如一种高效的膜,该膜能够在小设备尺寸下实现标准的毒素清除率。我们团队已经开发出纳米多孔氮化硅(NPN)膜,其厚度比传统膜薄100至1000倍,透析效率高出几个数量级。进行了逆流透析分离实验以测量尿素清除率,同时在搅拌烧杯中进行微透析实验以测量细胞色素c和白蛋白的分离情况。进行了测试血小板活化以及蛋白质粘附的血液透析实验。用于逆流实验的装置由聚二甲基硅氧烷(PDMS)和一个NPN膜芯片构建而成。逆流装置可将尿素减少多达20%。微透析实验表明,细胞色素c的扩散率约为60%,同时清除约20%的白蛋白。初步的血液相容性研究表明,与阳性对照(玻璃)相比,NPN膜表面较不易发生蛋白质粘附和血小板活化。